A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04129554 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: JNJ-73763989
DRUG: JNJ-56136379
DRUG: Placebo for JNJ-73763989
DRUG: Placebo for JNJ-56136379
DRUG: Entecavir (ETV) monohydrate
DRUG: Tenofovir disoproxil fumarate (TDF)
DRUG: Tenofovir alafenamide (TAF)

Sponsor

Janssen Sciences Ireland UC